Detection of outer membrane porin protein, an imipenem influx channel, in Pseudomonas aeruginosa clinical isolates

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 41, Issue 3, 2010, Pages 614-624

  Naenna, Penphun ^a   Noisumdaeng, Pirom ^b   Pongpech, Pintip ^a   Tribuddharat, Chanwit ^b  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Carbapenem resistance; OprD porin protein; Pseudomonas aeruginosa

Indexed keywords

BACTERIUM ANTIBODY; CARBAPENEM DERIVATIVE; IMIPENEM; MEROPENEM; OPRD PROTEIN, PSEUDOMONAS AERUGINOSA; PORIN; THIENAMYCIN DERIVATIVE;

ANTIBIOTIC RESISTANCE; ARTICLE; BIOSYNTHESIS; CLASSIFICATION; DRUG EFFECT; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; PHYSIOLOGY; PSEUDOMONAS AERUGINOSA;

ANTIBODIES, BACTERIAL; CARBAPENEMS; DRUG RESISTANCE, BACTERIAL; HUMANS; IMIPENEM; MICROBIAL SENSITIVITY TESTS; PORINS; PSEUDOMONAS AERUGINOSA; THIENAMYCINS;

EID: 77954698649     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Angus BL, Carey AM, Caron DA, Kropinski AM, Hancock RE. Outer membrane permeability in Pseudomonas aeruginosa: comparison of a wild-type with an antibiotic-supersusceptible mutant. Antimicrob Agents Chemother 1982; 21: 299-309
2. Ausubel F, Brent R, Kingston RE, et al. Short protocols in molecular biology: A compendium of methods from current protocols in molecular biology. 5th ed. John Wiley& Sons 2002
3. Chen HY, Yuan M, Livermore DM. Mechanisms of resistance to beta-lactam antibiotics amongst Pseudomonas aeruginosa isolates collected in the UK in 1993. J Med Microbiol 1995; 43: 300-309
4. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing; Fifteenth Informational Supplement 2005; 25(1), M100-S15. Baltimore, Maryland: CLSI, 2005
5. Farra A, Islam S, Stralfors A, Sorberg M, Wretlind B. Role of outer membrane protein OprD and penicillin-binding proteins in resistance of Pseudomonas aeruginosa to imipenem and meropenem. Int J Antimicrob Agents 2008; 31: 427-433
6. Fukuoka T, Ohya S, Narita T, et al. Activity of the carbapenem panipenem and role of the OprD (D2) protein in its diffusion through the Pseudomonas aeruginosa outer membrane. Antimicrob Agents Chemother 1993; 37: 322-327
7. Gotoh N, Nishino T. Decreases of the susceptibility to low molecular weight betalactam antibiotics in imipenem-resistant Pseudomonas aeruginosa mutants: role of outer membrane protein D2 in their diffusion. J Antimicrob Chemother 1990; 25: 191-198
8. Hidron AI, Edwards JR, Patel J, et al. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 2008; 29: 996-1011
9. Huang H, Hancock RE. The role of specific surface loop regions in determining the function of the imipenem-specific pore protein OprD of Pseudomonas aeruginosa. J Bacteriol 1996; 178: 3085-3090
10. Köhler T, Epp SF, Curty LK, Pechere JC. Characterization of MexT, the regulator of the MexE-MexF-OprN multidrug efflux system of Pseudomonas aeruginosa. J Bacteriol 1999a; 181: 6300-6305
11. Köhler T, Michea-Hamzehpour M, Epp SF, Pechere JC. Carbapenem activities against Pseudomonas aeruginosa: respective contributions of OprD and efflux systems. Antimicrob Agents Chemother 1999b; 43: 424-427
12. Köhler T, Michea-Hamzehpour M, Henze U, Gotoh N, Curty LK, Pechere JC. Characterization of MexE-MexF-OprN, a positively regulated multidrug efflux system of Pseudomonas aeruginosa. Mol Microbiol 1997; 23: 345-354
13. Kolayli F, Karadenizli A, Savli H, et al. Effect of carbapenems on the transcriptional expression of the oprD, oprM and oprN genes in Pseudomonas aeruginosa. J Med Microbiol 2004; 53: 915-920
14. Lagatolla C, Tonin EA, Monti-Bragadin C, et al. Endemic carbapenem-resistant Pseudomonas aeruginosa with acquired metallo-beta-lactamase determinants in European hospital. Emerg Infect Dis 2004; 10: 535-538
15. Lagatolla C, Edalucci E, Dolzani L, et al. Molecular evolution of metallo-beta-lactamase-producing Pseudomonas aeruginosa in a nosocomial setting of high-level endemicity. J Clin Microbiol 2006; 44: 2348-2353
16. Ochs MM, McCusker MP, Bains M, Hancock RE. Negative regulation of the Pseudomonas aeruginosa outer membrane porin OprD selective for imipenem and basic amino acids. Antimicrob Agents Chemother 1999; 43: 1085-1090
17. Page MG, Heim J. Prospects for the next anti-Pseudomonas drug. Curr Opin Pharmacol 2009; 9: 558-565
18. Pirnay JP, De Vos D, Mossialos D, Vanderkelen A, Cornelis P, Zizi M. Analysis of the Pseudomonas aeruginosa oprD gene from clinical and environmental isolates. Environ Microbiol 2002; 4: 872-882
19. Poole K. Outer membranes and efflux: the path to multidrug resistance in gram-negative bacteria. Curr Pharm Biotechnol 2002; 3: 77-98
20. Stover CK, Pham XQ, Erwin AL, et al. Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature 2000; 406: 959-964
21. Trias J, Nikaido H. Protein D2 channel of the Pseudomonas aeruginosa outer membrane has a binding site for basic amino acids and peptides. J Biol Chem 1990; 265: 15680-15684
22. Wolter DJ, Hanson ND, Lister PD. Insertional inactivation of oprD in clinical isolates of Pseudomonas aeruginosa leading to carbapenem resistance. FEMS Microbiol Lett 2004; 236: 137-143
23. Yoneyama H, Nakae T. Mechanism of efficient elimination of protein D2 in outer membrane of imipenem-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother 1993; 37: 2385-2390